Next Article in Journal
Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs
Next Article in Special Issue
IgG Fusion Proteins for Brain Delivery of Biologics via Blood–Brain Barrier Receptor-Mediated Transport
Previous Article in Journal
Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing
Previous Article in Special Issue
Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(7), 1452; https://doi.org/10.3390/pharmaceutics14071452
Action Date Notes Link
article xml file uploaded 12 July 2022 12:19 CEST Original file -
article xml uploaded. 12 July 2022 12:19 CEST Update https://www.mdpi.com/1999-4923/14/7/1452/xml
article pdf uploaded. 12 July 2022 12:19 CEST Version of Record https://www.mdpi.com/1999-4923/14/7/1452/pdf
article supplementary file uploaded. 12 July 2022 12:19 CEST - https://www.mdpi.com/1999-4923/14/7/1452#supplementary
article html file updated 12 July 2022 12:20 CEST Original file -
article html file updated 13 August 2022 01:21 CEST Update https://www.mdpi.com/1999-4923/14/7/1452/html
Back to TopTop